InvestorsHub Logo

stoneroad

10/01/14 12:15 PM

#192338 RE: wwtmm #192337

Completely disagree. As the Head of Regulatory Affairs and the only person on the management team/BOD with experience getting a drug through trials and approval his presence is critical.

BKT

10/01/14 12:35 PM

#192340 RE: wwtmm #192337


Having someone with Garnick's reputation and clout at the ASM meeting or any conference call, etc just gives more credibility to our already suspect BOD. His experience and expertise in the drug approval process is in my opinion second to none. I can't speak for anyone else, but he is one of the main reasons I have heavily invested in this company. I have often explained and promoted his credentials and experience to clients of mine to invest as well. If Robert Garnick can be involved in it, put his reputation on it, then it is good enough for me. For him to continue to show up and still be involved is further confirmation.